Longeveron Inc. (NASDAQ: LGVN) a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that ...

The study of the tumor ecosystem has progressed notably in recent years as cancer research shifts from a cell-intrinsic to a multi-compartmental ...

Key Points Interested in Surrozen, Inc.? Here are five stocks we like better. Surrozen is advancing a Wnt-based retina ...

This article is Part Two of a three-part community health series presented in partnership with Southern Kentucky Vascular, Somerset.

Yellow light therapy is gaining traction for calming redness and supporting skin repair. Dermatologists explain the benefits, ...

Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, has been awarded an Advanced Research Projects Agency for Health (ARPA-H) contract to develop advanced ...

NEWPORT NEWS, Va. and LONDON, July 22, 2026 /PRNewswire/ -- ivWatch, the IV safety company, today announced that its ...

Chronic insomnia was associated with higher risk for developing mild cognitive impairment and dementia, and individuals with reduced sleep had a higher rate of cognitive decline and more white matter ...

Vasomune Therapeutics, Inc. ("Vasomune"), a clinical-stage biopharmaceutical company developing therapies that target vascular leak, today announced that Dr. Harold Kim, Chief Scientific Officer, will ...

A new study by investigators from Mass General Brigham finds that nearly 1 in 3 U.S. adults without heart disease—and almost ...

What began as the final evening of a family vacation at Lake Powell turned into weeks in the hospital, 11 surgeries and an ...

As cancer survival rates improve, cardiovascular complications arising from anticancer therapies have emerged as a critical determinant of long-term patient ...